Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract A renewed focus on disease prevention has placed genomics firmly in the spotlight. Policymakers and health services across Europe are considering ways to facilitate disease prevention and early disease detection through population-level initiatives such as newborn genomic screening and polygenic risk scores. This commentary explores, through the lens of duty-based ethics, the ethical considerations in the design of genomic screening programmes. As genomic medicine becomes embedded in public health strategies, a robust ethical framework is essential to ensure that its promises are realised equitably and responsibly.

More information Original publication

DOI

10.1038/s41431-026-02133-7

Type

Journal article

Publisher

Springer Science and Business Media LLC

Publication Date

2026-05-16T00:00:00+00:00